IFNγ and TNFα production triggered in NK cells against these tumor cells was significantly lower than that induced by TriKE in response to NCI-H460, for all disease stages (I-IVB) and timepoints (before treatment, after treatment or at progression). This evidence concerns the gene TNF and neoplasm.